ECL vs REPL
Ecolab Inc (ECL) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
REPL does not have a complete income-statement cache yet.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. REPL currently screens at market cap $825.7M.
Not investment advice. Open the ECL and REPL stock pages for the full models.
Not investment advice.